194 related articles for article (PubMed ID: 23637120)
21. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
22. The value of endothelin receptor type B promoter methylation as a biomarker for the risk assessment and diagnosis of prostate cancer: A meta-analysis.
Yuan Y; Du Y; Wang L; Liu X
Pathol Res Pract; 2020 Feb; 216(2):152796. PubMed ID: 31926772
[TBL] [Abstract][Full Text] [Related]
23. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
Mousavi Ardehaie R; Hashemzadeh S; Behrouz Sharif S; Ghojazadeh M; Teimoori-Toolabi L; Sakhinia E
Bioengineered; 2017 Sep; 8(5):555-564. PubMed ID: 28140749
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort.
de Freitas Cordeiro-Silva M; Stur E; Agostini LP; de Podestá JR; de Oliveira JC; Soares MS; Mendonça EF; Gouvea SA; Von Zeidler SV; Louro ID
Mol Biol Rep; 2012 Dec; 39(12):10111-9. PubMed ID: 22936053
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer.
Tao K; Wu C; Wu K; Li W; Han G; Shuai X; Wang G
Med Oncol; 2012 Mar; 29(1):107-12. PubMed ID: 21264540
[TBL] [Abstract][Full Text] [Related]
26. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
27. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
28. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
[TBL] [Abstract][Full Text] [Related]
29. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.
Lo KW; Tsang YS; Kwong J; To KF; Teo PM; Huang DP
Int J Cancer; 2002 Apr; 98(5):651-5. PubMed ID: 11920632
[TBL] [Abstract][Full Text] [Related]
32. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
Jerónimo C; Henrique R; Campos PF; Oliveira J; Caballero OL; Lopes C; Sidransky D
J Clin Pathol; 2003 Jan; 56(1):52-5. PubMed ID: 12499435
[TBL] [Abstract][Full Text] [Related]
33. Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.
Viet CT; Ye Y; Dang D; Lam DK; Achdjian S; Zhang J; Schmidt BL
Pain; 2011 Oct; 152(10):2323-2332. PubMed ID: 21782343
[TBL] [Abstract][Full Text] [Related]
34. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
35. Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma.
de Freitas Cordeiro-Silva M; Oliveira ZF; de Podestá JR; Gouvea SA; Von Zeidler SV; Louro ID
Mol Biol Rep; 2011 Nov; 38(8):5435-41. PubMed ID: 21380558
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
Reddy VR; Annamalai T; Narayanan V; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
[TBL] [Abstract][Full Text] [Related]
38. Screening for oral premalignancy and cancer: what platform and which biomarkers?
Lingen MW
Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
[TBL] [Abstract][Full Text] [Related]
39. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
[TBL] [Abstract][Full Text] [Related]
40. Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma.
Lee E; Lee BB; Ko E; Kim Y; Han J; Shim YM; Park J; Kim DH
Cancer; 2013 May; 119(9):1752-60. PubMed ID: 23310950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
